Living with SMA? Your experience could help shape the future of care
This article was provided by our partner, the Muscular Dystrophy Association. It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and do not necessarily reflect the views of Bionews or SMA News Today.
For people living with spinal muscular atrophy (SMA) and the families who support them, the last several years have brought something many of us once only hoped for: meaningful treatment progress.
As someone who has lived with SMA my entire life, I’ve seen firsthand how dramatically the landscape has changed. Today, people with SMA are living longer, experiencing new possibilities, and navigating a very different care journey than generations before us. Treatments are changing outcomes. Earlier diagnoses are changing trajectories. And for many families, hope now looks more tangible than ever.
But while clinical trials helped bring these therapies to the community, there is still so much we need to understand, not just about life with SMA, but how life with SMA is changing as our health improves. That’s why I chose to enroll in MOVR 2.0 — the Muscular Dystrophy Association’s next-generation real-world data platform focused on neuromuscular diseases.
MOVR 2.0 builds on years of research collaboration by combining clinical information with patient-reported experiences to better understand what truly matters to people living with SMA. It looks beyond medical charts to capture things like quality of life, functional changes, access to care, caregiver experiences, and the day-to-day realities that are often difficult to measure in traditional research settings.
For the SMA community, this kind of long-term, real-world evidence is becoming increasingly important.
We are now in a new era in which researchers, clinicians, advocates, and policymakers are asking critical questions: How do treatments impact people years later? What barriers still exist for families? What support services are missing? How do we ensure access to care remains equitable and sustainable? And what unmet needs continue to affect people living with SMA across different stages of life?
The answers to those questions cannot come from researchers alone. They must come directly from patients and caregivers willing to share their lived experiences. Participation in MOVR 2.0 helps strengthen our collective understanding of SMA in ways that may improve future clinical care, support advocacy efforts, inform reimbursement and access discussions, and help researchers prepare for future clinical trials and treatment development. Just as importantly, it helps ensure that patient voices remain at the center of decisions shaping the future of SMA care. As we’ve said so many times before, “nothing for us without us.” This is an exciting opportunity to help steer the ship of research and care.
For families considering participation, I understand that joining a research initiative can sometimes feel intimidating. But my own experience enrolling in MOVR 2.0 was straightforward and empowering. I viewed it as an opportunity to contribute not only to research, but to contribute to a broader understanding of what it means to live with SMA today.
Every story matters. Every lived experience adds another piece to the picture.
The SMA community has already helped drive extraordinary progress through advocacy, research participation, and shared resilience. MOVR 2.0 represents another opportunity to shape what comes next — together.
The post Living with SMA? Your experience could help shape the future of care appeared first on SMA News Today.
